Discover SKYRIZI® (risankizumab-rzaa), a biologic treatment for adults with Active Psoriatic Arthritis (PsA). See Full Safety and Prescribing Information.

How Quickly Will Skyrizi Work for Psoriatic Arthritis? If Skyrizi is working, your symptoms will start to improve over the first 1-2 months.

Is skyrizi used to treat psoriatic arthritis Is skyrizi used to treat psoriatic arthritis Skyrizi, known generically as risankizumab, is a relatively new biologic medication that has gained prominence in …

Mar 24, 2025 · Skyrizi (also known by its generic name risankizumab-rzaa) is a biologic medication that was approved by the FDA in April 2019 for the treatment of moderate-to-severe plaque psoriasis in …

Indications Plaque Psoriasis: SKYRIZI is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Psoriatic Arthritis: …

Jun 20, 2024 · Skyrizi studies in psoriatic arthritis The Skyrizi (risankizumab-rzaa) approval for psoriatic arthritis was supported by two Phase 3, placebo controlled studies, KEEPsAKE-1 and KEEPsAKE-2. …

Jan 25, 2022 · Psoriasis and psoriatic arthritis (PsA) are clearly closely connected, which is why some medications work for people with either diagnosis. Now psoriatic arthritis patients have an additional …

May 26, 2024 · The dosing regimen of Skyrizi for psoriatic arthritis is consistent with the regimen for moderate-to-severe plaque psoriasis, which is a single 150-mg subcutaneous injection four times a …

Learn about Psoriatic Arthritis (PsA), diagnosis, what to tell your doctor, and available treatment options. See Full Safety and Prescribing Information.

Jul 3, 2025 · Psoriatic arthritis (PsA) can cause joint inflammation and pain that ranges from mild to severe. Learn about the 5 subtypes of PsA, their symptoms, causes, diagnosis, and treatment.